Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Calls of the Day: Gilead Sciences and Merck
12:59pm, Tuesday, 18'th Feb 2025
The Investment Committee debate the Calls of the Day in two biotech names.
Exclusive: Merck vaccine case linked to HHS Secretary Kennedy delayed, company says
11:48am, Tuesday, 18'th Feb 2025
Merck and a woman suing the drugmaker agreed to halt a trial over alleged injuries from the drugmaker's human papillomavirus vaccine in a case with ties to U.S. Department of Health and Human Services
Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky
11:30am, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities la
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Mer
Merck & Co., Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
11:00am, Tuesday, 18'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. ("Merc
Investors Who Lost Money on Merck & Co., Inc. (MRK) Should Contact Levi & Korsinsky About Pending Class Action - MRK
10:45am, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities la
MRK Investors Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm
10:21am, Tuesday, 18'th Feb 2025
LOS ANGELES , Feb. 18, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Merck & Co., Inc. ("Merck" or "the
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders
07:25am, Tuesday, 18'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities la
NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Me
WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
06:45am, Tuesday, 18'th Feb 2025
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--WELIREG Receives First European Commission Approval for Two Indications.
Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK
05:45am, Tuesday, 18'th Feb 2025
NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. ("Merck" or the "Company") (NYSE: MRK) of a class action securities lawsuit. CLASS DEFINITION: T
NEW YORK--(BUSINESS WIRE)---- $MRK #ClassAction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been fil
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities la
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Mer
Lost Money on Merck & Co., Inc. (MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
11:30am, Monday, 17'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 17, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities la
